| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |